1. Home
  2. SUPN vs PBH Comparison

SUPN vs PBH Comparison

Compare SUPN & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

SELL

Current Price

$37.86

Market Cap

2.5B

Sector

Health Care

ML Signal

SELL

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

SELL

Current Price

$50.11

Market Cap

2.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SUPN
PBH
Founded
2005
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
2010
2004

Fundamental Metrics

Financial Performance
Metric
SUPN
PBH
Price
$37.86
$50.11
Analyst Decision
Buy
Buy
Analyst Count
4
7
Target Price
$60.50
★ $67.80
AVG Volume (30 Days)
★ 627.8K
548.8K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.61
Revenue
$392,755,000.00
★ $975,777,000.00
Revenue This Year
$22.95
$17.03
Revenue Next Year
$54.39
$6.06
P/E Ratio
★ N/A
$80.70
Revenue Growth
N/A
★ 36.77
52 Week Low
$39.36
$42.62
52 Week High
$59.68
$71.07

Technical Indicators

Market Signals
Indicator
SUPN
PBH
Relative Strength Index (RSI) 27.30 60.51
Support Level N/A $49.73
Resistance Level $52.33 $51.57
Average True Range (ATR) 1.58 1.22
MACD -0.38 0.52
Stochastic Oscillator 6.09 85.48

Price Performance

Historical Comparison
SUPN
PBH

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Share on Social Networks: